PubMed Health⌕ Search

Biomedical subjects

R Alberca

Publications and source records attributed to R Alberca.

At least 19 recordsLinked to original sources

Prophylactic treatment of episodic cluster headache with intravenous bolus of methylprednisolone.

We evaluated the efficacy of intravenous boluses of methylprednisolone followed by prednisone as a prophylactic treatment for episodic cluster headache. Fourteen male patients (mean age, 42.54 years) with episodic cluster headache were treated with 250-mg boluses of methylprednisolone on 3 consecutive days, followed by prednisone (90 mg/day orally) with gradual tapering in four weeks. Headache parameters of the active phases treated with methylprednisolone were compared with those of previous active phases in the same patients treated with other prophylactic medications. The primary efficacy criterion was decrease in the frequency of attacks during the first month of treatment. The statistical differences were calculated using Wilcoxon's test. The attacks were significantly less frequent in the active phases treated with methylprednisolone boluses than those treated with other medications ( p<0.05). This treatment seems to be more effective than the usual prophylactic treatments for episodic cluster headache.

Adult↗

Transient topographical disorientation.

Transient topographical disorientation (TTD) is a short-lasting inability to find one's way in a familiar environment, while the patient remains conscious and is able to recall what happened. We report the study of 10 patients with episodes of TTD, studied on the days following the last episode. The episodes of TTD could be separated into two types: the patients either reported difficulties in spatial orientation with preserved abilities to recognize landmarks and objects, or the difficulties appeared with the recognition of landmarks. Tests exploring spatial orientation, as well as higher visuoperceptive capacities were altered in most of the patients and brain SPECT showed hypoperfusion of the right hemisphere in all patients, which could also be demonstrated 2 years later in some cases. Altogether, our findings suggest that TTD is frequently associated with a more persistent right hemisphere dysfunction of unknown cause. This chronic alteration could represent either a sequel of the acute episode or a preexisting right hemisphere deficit, which inclined the acute insult to be manifested as TTD.

Adult↗

Statuslike SUNCT in two young women.

OBJECTIVE: To describe the statuslike pattern of SUNCT (short-lasting unilateral neuralgiform pain with conjunctival injection and tearing) in two young women. BACKGROUND: SUNCT syndrome is a rare condition characterized by a short-lasting periocular pain associated with marked autonomic symptoms. Twenty-five cases have been reported in the literature with a high preponderance of males and a mean age of 51 years. The frequency of episodes shows a wide variability, not just among individuals but also in the same patient, and a statuslike pattern of almost continuous attacks has been described. METHODS: We report the cases of two young women (aged 26 and 23 years) with typical SUNCT features who suffered bouts of up to 60 paroxysms of pain per hour. Paraclinical investigations showed no abnormalities. CONCLUSIONS: Although unusual, paroxysms in SUNCT may overlap into a clinical status. A strong relationship with hormonal changes was noted in one patient. In both cases, the pain was refractory to treatment with indomethacin, carbamazepine, and hypnotics, and only intravenous methylprednisolone with oral carbamazepine may have been partially effective in one case.

Adult↗

[Psychotic symptoms and Alzheimer's disease].

BACKGROUND: Psychotic symptoms appear during the course of Alzheimer's disease, but their frequency and intensity vary according to different studies and their nature remains unsettled. OBJECTIVES: To study the frequency and intensity of psychotic symptoms in two transversal series of patients with Alzheimer's disease and analyze its relationship with the duration of the disease and severity of cognitive impairment. PATIENTS AND METHODS: This study has been carried out in patients suffering from probable Alzheimer's disease (NINDS-ADRDA criteria). The stage of the disease was determined according to FAST, and the intensity of cognitive impairment in Mini Mental State Examination was classified as mild, moderate or severe. Frequency and intensity of psychotic symptoms (delusions, hallucinations and misidentifications) were determined by means of semistructured interviews (BEHAVE-AD 78 patients and CUSPAD 69 patients). The results obtained in these three groups of patients were compared through ANOVA variance analysis and mean contrast. Variance and covariance analysis were done to determine the relationship between psychotic symptoms and other variables (degree of cognitive impairment, length of evolution and stage of the disease). For this purpose, the patients with Alzheimer's disease but without psychotic symptoms were considered as control and compared to patients with psychotic symptoms. RESULTS: Nearly half the patients had psychotic symptoms. Delusions appeared earlier and were more frequent than hallucinations and misinterpretations. The more severe was the cognitive impairment, the more frequent and intense were psychotic symptoms, but the difference was significant only in cases with severe cognitive impairment. Hallucinations appeared mainly in patients with advanced dementia and were related firstly with the intensity of functional and cognitive impairment and secondly with the duration of the disease. CONCLUSIONS: Mild psychotic symptoms, especially delusions, appear early during the course of Alzheimer's disease. The frequency and intensity of these symptoms increase in parallel with the functional and cognitive impairments caused by the disease. Hallucinations, which appear mainly when the dementia is severe, can be considered as an evolutive marker of the process. Psychotic symptoms differ from those occurring in other disorders, either neurologic or psychiatric in nature.

Aged↗

[Spanish study of quality of life in migraine (II). Profile of medication consumption and subjective efficacy].

OBJECTIVES: The response to the different antimigraine medications is variable. In this study we have analysed the profile of prescription of these antimigraine medications, both preventive and symptomatic, by a group of spanish neurologists and examined the subjective efficacy of these compounds. PATIENTS AND METHODS: Neurologists from 7 hospitals in different spanish regions interviewed 305 patients (at least 40 per hospital) who met migraine diagnostic criteria. They used an ad hoc questionnaire in which the antimigraine medications, both symptomatic and preventive, taken by the patients, as well as their subjective response were registered. Patients with transformed migraine or tension-type headache more than 2 days per week were excluded. RESULTS: Analgesics, non-steroidal anti-inflammatory drugs, ergotics and sumatriptan had been taken by 99, 69, 54 and 40% of the 305 interviewed patients, respectively. A subjective good response was refered to by 9% of patients who had taken analgesics, 23% of patients who had taken non-steroidal anti-inflammatory drugs, 39% of those who had taken ergotics and 63% of patients with sumatriptan. The current symptomatic treatment was: analgesics 34% of cases, non-steroidal anti-inflamatory drugs 26%, ergotics 13% and sumatriptan 63%. Regarding preventive treatments, 108 patients (35%) had been treated with calcium-antagonists, 87 (29%) with beta-blockers, 55 (18%) with amitriptyline and only 7 (2.2%) with valproic acid. The percentages of good responses to these drugs were: 55% for beta-blockers, 42% for calcium-antagonists and 31% for amitriptyline. CONCLUSIONS: Our data confirm that analgesics are not efficacious in the majority of migraine patients and that the advent of sumatriptan has clearly improved the quality of migrane symptomatic treatment, even though about one-third of migraine patients do not respond to this drug. This study confirm that calcium-antagonists are the antimigraine preventive treatment most frequently prescribed in our country, even though their subjective efficacy is lower than that of beta-blockers.

Analgesics, Non-Narcotic↗

[Epilepsy and migraine].

Migraine and epilepsy are two clearly different syndromes. All they have in common is that both cause paroxystic neurological phenomena. However, the frequency of epilepsy in patients with migraine, and migraine in those with epilepsy seems to be higher than one would expect. This suggests there may be comorbidity in both conditions. Analysis of this comorbidity is very important since it may give clues as to the physio-pathology and aetiology of certain disorders. This paper analyses the existence of migraine-epilepsy comorbidity and the levels at which it occurs. This coexistence may be due to the episode of one, for example the aura of a migrainous attack, triggering off the other condition, that is an epileptic crisis. So, it may be that the 'migrainous illness' causes the 'epileptic illness' or the other way around. Their coexistence may be due to a risk factor which is common to both, since it has caused a cerebral lesion which is the cause of both disorders. Finally, a risk factor may have a direct effect, without requiring the intervention of an intermediate cerebral lesion to cause both migraine and epilepsy. This last possibility is particularly attractive to explain the comorbidity of migraine with an aura and genetically determined epilepsy.

Brain Diseases↗

[Usefulness of SPECT in the study of Alzheimer's disease].

Single-photon emission photometry (SPECT) images of the brains of 60 patients with Alzheimer's disease (AD) were compared with the brain scans of 16 healthy controls of the same sex and similar ages. SPECT was repeated one year later in 16 of the AD patients. Perfusion indices for frontal, parietal, temporal and occipital regions of patients and controls were compared (Student's tests). Flow alterations were located and symmetry examined. The correlation between perfusion index for each cortical area and MMSE score was assessed (Pearson's r). Perfusion alterations were present in all except one AD patient, and in 65% of AD patients such alterations were in the parietotemporal cortex. Severity of cognitive impairment in AD patients was related to perfusion changes in the left posterior temporal region. Forty-four AD patients showed asymmetrical distribution of tracer and in 73% perfusion changes were predominantly in the left hemisphere. Altered brain blood flow is common in AD and onset is early. The parietotemporal location of defective perfusion is of great diagnostic value. Asymmetry is common and the left hemisphere is most often affected.

Aged↗

[Unusual varieties of cluster headache].

Atypical forms of cluster headache (CH) are characterized by the association of CH to other headaches and facial neuralgias. Cluster-tic syndrome causes headaches similar to CR and pains similar to trigeminal neuralgia. The disorder is usually of unknown nature and its course is either episodic or chronic. Carbamazepine together with medication for CH is the treatment of choice. A characteristic sensory aura usually develops immediatedly before the attacks of headache in CH-Migraine (CHM). These attacks respond dramatically to subcutaneous sumatriptan and the prophylaxis of CHM is that of CH. CH variant comprises different types of pain and responds to indomethacin. Other unusual varieties of CH are the subchronic and the combined forms, probably related to chronic CH. Finally, the characteristics of CH may be modified by its treatment and chronic abuse of steroids may change the evolution of an episodic CH into a chronic unilateral paroxysmal headache with resembles to but is different from chronic CR. This headache could be called transformed CH (TCH) and to the best of our knowledge the disorder has not been reported up to now. TCH goes undiagnosed and does not respond to the usual treatments of CH. Patients suffering from TCH are frequently sent for surgical treatment which is absolutely contraindicated. Withdrawal of steroids, which is difficult to accomplish, changes TCH into a the former and typical episodic CH, which can now be treated in the usual way.

Adolescent↗

[Late onset epilepsy].

Epileptic seizures appearing in adulthood are not uncommon. They are usually provoked or involve acute symptoms, but late-onset unprovoked seizures are also frequent. The chance of repeated seizures is high, and when they occur late-onset epilepsy (LOE) is diagnosed. The incidence of LOE, particularly in the elderly, has increased over the past ten years. The etiology of this entity depends to a great extent on age. Idiopathic LOE is quite frequent, especially in the young adult and new epileptic syndromes have recently been described. The percentage of LOE cases attributable to tumors and traumatism is high in the middle-aged adult. Vascular disease and dementia are the main causes of LOE in the elderly. The treatment of LOE follows the general guidelines, but the starting drug doses must be lower and certain antiepileptic must be avoided in the elderly. Seizures are often controlled by a single drug given at comparatively low doses. New longitudinal studies are needed, however, to allow us to formulate new rational therapeutic approaches.

Adolescent↗

[Sumatriptan and cluster headache].

Double-blind studies have demonstrated the efficacy of sumatriptan for the treatment of cluster headache (CH) but little is known about its use on a daily basis. The open trial reported here analyzed the efficacy, tolerance and appropriateness of subcutaneous administration of sumatriptan; the results are compared with findings for other treatments of CH. Sumatriptan was used in 232 attacks suffered by 16 patients and its effect was very rapid. Pain began to diminish a mean 9 minutes after injection and the most intense had disappeared in less than 15 minutes. All the patients preferred sumatriptan to other treatments. No serious side effects were recorded and the patients were satisfied with subcutaneous injection. Sumatriptan was considered the first choice medication for treatment of CH symptoms, although its high cost is a drawback that had to be taken into account.

Adolescent↗